Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Capital Expenditures (2016 - 2025)

InfuSystem Holdings (INFU) has disclosed Capital Expenditures for 16 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 224.85% year-over-year to $2.7 million, compared with a TTM value of $3.1 million through Dec 2025, up 123.72%, and an annual FY2025 reading of $3.1 million, up 123.72% over the prior year.
  • Capital Expenditures was $2.7 million for Q4 2025 at InfuSystem Holdings, up from $79000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $2.7 million in Q4 2025 and bottomed at -$367000.0 in Q4 2023.
  • Average Capital Expenditures over 5 years is $334400.0, with a median of $189000.0 recorded in 2021.
  • The sharpest move saw Capital Expenditures soared 618.06% in 2021, then plummeted 189.29% in 2023.
  • Year by year, Capital Expenditures stood at $373000.0 in 2021, then rose by 10.19% to $411000.0 in 2022, then crashed by 189.29% to -$367000.0 in 2023, then skyrocketed by 323.71% to $821000.0 in 2024, then surged by 224.85% to $2.7 million in 2025.
  • Business Quant data shows Capital Expenditures for INFU at $2.7 million in Q4 2025, $79000.0 in Q3 2025, and $217000.0 in Q2 2025.